SCHEMBL2833732

SCHEMBL2833732

Cc1cc(C2(c3cc(C)c(O)cc3C)OC(=O)c3ccccc32)c(C)cc1O

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.73
LMNA P02545 6/20 0.73
NPSR1 Q6W5P4 3/20 0.73
CYP3A4 P08684 3/20 0.73
CYP2C19 P33261 2/20 0.73
TP53 P04637 2/20 0.73
ALOX15 P16050 2/20 0.73
CYP1A2 P05177 1/20 0.73
CYP2D6 P10635 1/20 0.73
CYP2C9 P11712 1/20 0.73
PAX8 Q06710 1/20 0.73
HIF1A Q16665 1/20 0.73
POLB P06746 2/20 0.69
GPR55 Q9Y2T6 2/20 0.69
ALOX12 P18054 1/20 0.69
TDP1 Q9NUW8 5/20 0.68
MEN1 O00255 5/20 0.68
KMT2A Q03164 5/20 0.68
SMN1; SMN2 Q16637 2/20 0.68
L3MBTL1 Q9Y468 2/20 0.68

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30312328 1.00 MAPT (0.73) MAPTLMNANPSR1CYP3A4CYP2C19
SCHEMBL14750827 0.87 MAPT (0.64) MAPTLMNANPSR1CYP3A4CYP2C19
SCHEMBL62717 0.85 MAPT (0.73) MAPTLMNANPSR1CYP3A4CYP2C19
SCHEMBL29559864 0.85 MAPT (1.00) MAPTLMNANPSR1CYP3A4CYP2C19
SCHEMBL62716 0.85 MAPT (1.00) MAPTLMNANPSR1CYP3A4CYP2C19
SCHEMBL29942223 0.85 MAPT (1.00) MAPTLMNANPSR1CYP3A4CYP2C19
Methyl Alcohol SCHEMBL28942674 0.84 MAPT (0.97) MAPTLMNANPSR1CYP3A4CYP2C19
SCHEMBL8377649 0.84 MAPT (0.97) MAPTLMNANPSR1CYP3A4CYP2C19
SCHEMBL8377651 0.84 MAPT (0.71) MAPTLMNANPSR1CYP3A4CYP2C19
SCHEMBL4960577 0.83 MAPT (0.62) MAPTLMNANPSR1CYP3A4CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8216770-B2 aromatic polyester copolymer is alkali-developable photosensitive or thermal curable; used to form pattern on filter which exhibit physical properties resist to heat and chemicals, improve developability, and adhesiveness, high resolution; use for Liquid crystal display devices CHEIL INDUSTRIES INC. (KR) 2012-07-10 US claimed
EP-1871844-B1 BUBBLE COMPOSITION WITH COLOR CHANGING INDICATOR C2C TECHNOLOGIES LLC (US) 2014-08-27 EP disclosed
EP-1871844-B1 BUBBLE COMPOSITION WITH COLOR CHANGING INDICATOR C2C TECHNOLOGIES LLC (US) 2014-08-27 EP disclosed
US-8216770-B2 aromatic polyester copolymer is alkali-developable photosensitive or thermal curable; used to form pattern on filter which exhibit physical properties resist to heat and chemicals, improve developability, and adhesiveness, high resolution; use for Liquid crystal display devices CHEIL INDUSTRIES INC. (KR) 2012-07-10 US disclosed
US-20100163811-A1 Organic Layer Photosensitive Resin Composition and Organic Layer Fabricated Using Same CHEIL INDUSTRIES INC. (KR) 2010-07-01 US disclosed
WO-2008047992-A1 RESIN COMPOSITION COMPRISING CARDO RESIN, METHOD FOR FORMING PATTERN USING THE RESIN COMPOSITION AND COLOR FILTER USING PATTERN FORMED BY THE METHOD CHEIL INDUSTRIES INC. (KR) 2008-04-24 WO disclosed
US-20080090177-A1 Resin Composition Comprising Cardo Resin, Method for Forming Pattern Using the Resin Composition and Color Filter Using Pattern Formed by the Method CHEIL INDUSTRIES INC. (KR) 2008-04-17 US disclosed
EP-1871844-A2 NOVELTY COMPOSITIONS WITH COLOR CHANGING INDICATOR C2C Technologies LLC (US) 2008-01-02 EP disclosed
WO-2007008389-A2 USE OF COLOR CHANGING INDICATORS IN CONSUMER PRODUCTS C2C TECHNOLOGIES LLC (US) 2007-01-18 WO disclosed
WO-2007008389-A2 USE OF COLOR CHANGING INDICATORS IN CONSUMER PRODUCTS C2C TECHNOLOGIES LLC (US) 2007-01-18 WO disclosed
US-20060257439-A1 Cleansing compositions with color changing indicator CRAYOLA LLC 2006-11-16 US disclosed
US-20060236470-A1 Novelty compositions with color changing indicator CRAYOLA LLC 2006-10-26 US disclosed
WO-2006105193-A2 PERSONAL CARE COMPOSITIONS WITH COLOR CHANGING INDICATOR C2C TECHNOLOGIES LLC (US) 2006-10-05 WO disclosed
WO-2006105260-A1 ORAL CARE COMPOSITIONS WITH COLOR CHANGING INDICATOR C2C TECHNOLOGIES LLC (US) 2006-10-05 WO disclosed
WO-2006105261-A1 CLEANSING COMPOSITIONS WITH COLOR CHANGING INDICATOR C2C TECHNOLOGIES LLC (US) 2006-10-05 WO disclosed
WO-2006105191-A2 NOVELTY COMPOSITIONS WITH COLOR CHANGING INDICATOR C2C TECHNOLOGIES LLC (US) 2006-10-05 WO disclosed
US-20060222675-A1 Personal care compositions with color changing indicator C2C TECHNOLOGIES, LLC 2006-10-05 US disclosed
US-20060222601-A1 Oral care compositions with color changing indicator C2C TECHNOLOGIES, LLC 2006-10-05 US disclosed
US-5231195-A Monomers for opthalmic lenses PPG INDUSTRIES, INC. (US) 1993-07-27 US disclosed
US-4954544-A POLYVINYLPYRROLIDONE, NONIONIC SURFACTANT, CARBAMIDE, INDICATOR CONROS CORPORATION (CA) 1990-09-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060222675-A1 Personal care compositions with color changing indicator CUTA, POLR1C, TYR MAPT 2485/4885LMNA 603/4885NPSR1 4409/4885
US-20060257439-A1 Cleansing compositions with color changing indicator WASHC5, WASHC4, FHIT MAPT 3034/4885LMNA 1851/4885NPSR1 4565/4885
US-20060222601-A1 Oral care compositions with color changing indicator CA9, CA7, TAS2R7 MAPT 3664/4885LMNA 2157/4885NPSR1 4543/4885
US-20060236470-A1 Novelty compositions with color changing indicator MITF, CRABP2, SHH MAPT 720/4885LMNA 3242/4885NPSR1 352/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.